President and Representative Director
Meiji Animal Health Co., Ltd.

Dr. Kazuhiko Hirose graduated from Kitasato University’s School of Veterinary Medicine in 1991 and earned a Ph.D. in Veterinary Medicine in 2004. He joined Meiji Seika Co. Ltd. in 1992 as a Research Scientist and is currently serving as President and Representative Director of Meiji Animal Health Co., Ltd. 

Prior to his appointment as President of Meiji Animal Health, Dr. Hirose held various leading roles in Veterinary Research and Development at Meiji Seika, amongst others as Chief of the Technical Service Group and Head of the Livestock and Aquaculture Group. Furthermore, he also held a role as a visiting professor at the Department of Agriculture at Shinshu University, Japan.

Subsequently he moved into the commercial arm of the business and in 2021 was appointed as Managing Director for the Agricultural and Veterinary Division and in 2022 he has been appointed to his current position as President Meiji Animal Health Co. Ltd.

Outside of his role at Meiji Animal Health, Dr. Hirose holds further appointments including Director of the Japanese Society of Antimicrobials for Animals, Director of the Japanese Society of Animal Hygiene, Director of the Japan Veterinary Products Association, Member of the JMAFF committee for Revision  on  the Prevention of Infectious Diseases.

Other speakers

Sven Arnouts Business Development Manager Ghent University - Provaxs
Klaus Hellmann Chief Veterinary Officer Argenta
Johannes Charlier Managing Director Kreavet
Nathalie Vanderheijden Coordinator fot the European Partnership on Animal Health and Welfare Ghent University
Laetitia Cicchelero Cross-Health platform coordinator - Provaxs University of Ghent
Hervé Poulet Director of Strategic Partnering Boehringer-Ingelheim Animal Health
Sebastiaan Theuns CEO & co-founder PathoSense
Dieter Vancraeynest External Innovation Zoetis
Beatrice Vos Partner Stonehaven Cozmix Group (SC Group)
Bryan Charleston Director and CEO The Pirbright Institute
Stewart Burgess Head of Department of Vaccines & Diagnostics Moredun Research Institute
Inne Xhonneux Project Advisor Life Sciences Flanders Innovation & Entrepreneurship (VLAIO)
Hanjo Hennemann Co-founder and CEO Verovaccines
Juerg Baggenstoss Partner Stonehaven Cozmix Group
Paul Dick Founder and President Paul Dick and Associates
Steve Nanchen Head External Innovation - R&D Elanco Animal Health
Erwin Blomsma CEO and Co-Founder Virovet
Alfonso Martín-Fontecha Business Development Manager Laboratorios SYVA
Valerio Abbadessa Research Programme Officer EC DG AGRI, F2 R&I
Paul Horwood UK Head of Farm & Exports IVC Evidensia
Daisy Vanrompay Director of the Laboratory of Immunology and Animal Biotechnology Ghent University
Jennifer Serriere-Di Bartolo Biopharma Strategic Collaboration & Marketing Manager Promega
Jens Radzimanowski Director of Antibody Therapeutics Lead Identification Boehringer Ingelheim
Pieter-Jan Serreyn Technical Director AnimalhealthEurope
Charles Owen Founder and CEO 272Bio Limited
Jeremy Gowler Chief Executive Officer Ophirex, Inc.
Ralf Herold Head of Regulatory Science and Academia, Task force Regulatory Science and Innovation, EMA European Medicines Agency

Registrations are now open